Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferritarg P
- Development stage
- Discontinued
- Lead developer
- MAT Biopharma
- Modality
- Alpha Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta Emitters → Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Ferritarg P is a rabbit polyclonal antibody engineered to recognize acidic ferritin, a protein found at elevated levels in cancer cells. It functions by binding to these ferritin antigens, and when labeled with radionuclides such as Yttrium-90 (90Y), it delivers localized radiation to cancer cells, causing DNA damage and ultimately cell death. It has also been used with Indium-111 (111In) for diagnostic imaging. Ferritarg P received orphan drug designation from the European Union in 2003 and the United States FDA in 2006 for Hodgkin's disease. Developed by MAT Biopharma, its clinical advancement has been stalled since 2008.
- Brand names
- Ferritarg P
- Other names
- Ferritarg
Beyond the preview
Go deeper on Ferritarg P.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ferritarg P.